These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10380970)

  • 21. Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion.
    Nielsen KM; Soghomonian JJ
    Synapse; 2003 Sep; 49(4):246-60. PubMed ID: 12827644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal activity in the medial associative-limbic and lateral motor part of the rat subthalamic nucleus and the effect of 6-hydroxydopamine-induced lesions of the dorsolateral striatum.
    Lindemann C; Alam M; Krauss JK; Schwabe K
    J Comp Neurol; 2013 Oct; 521(14):3226-40. PubMed ID: 23787707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease.
    Rizelio V; Szawka RE; Xavier LL; Achaval M; Rigon P; Saur L; Matheussi F; Delattre AM; Anselmo-Franci JA; Meneses M; Ferraz AC
    Braz J Med Biol Res; 2010 Jan; 43(1):85-95. PubMed ID: 19967265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lesions of the entopeduncular nucleus and the subthalamic nucleus reduce dopamine receptor antagonist-induced catalepsy in the rat.
    Zadow B; Schmidt WJ
    Behav Brain Res; 1994 May; 62(1):71-9. PubMed ID: 7917035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
    Hassani OK; Féger J
    Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
    Iribe Y; Moore K; Pang KC; Tepper JM
    J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.
    Vila M; Périer C; Féger J; Yelnik J; Faucheux B; Ruberg M; Raisman-Vozari R; Agid Y; Hirsch EC
    Eur J Neurosci; 2000 Jan; 12(1):337-44. PubMed ID: 10651888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.
    Efange SM; Langason RB; Khare AB; Low WC
    Life Sci; 1996; 58(16):1367-74. PubMed ID: 8614294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
    Breit S; Lessmann L; Benazzouz A; Schulz JB
    Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid.
    Nakao N; Nakai E; Nakai K; Itakura T
    Ann Neurol; 1999 May; 45(5):640-51. PubMed ID: 10319887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.
    Vila M; Marin C; Ruberg M; Jimenez A; Raisman-Vozari R; Agid Y; Tolosa E; Hirsch EC
    J Neurochem; 1999 Jul; 73(1):344-52. PubMed ID: 10386987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences.
    Mourre C; Manrique C; Camon J; Aidi-Knani S; Deltheil T; Turle-Lorenzo N; Guiraudie-Capraz G; Amalric M
    Neuropharmacology; 2017 Feb; 113(Pt A):519-532. PubMed ID: 27825825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic control of the globus pallidus through activation of D2 receptors and its impact on the electrical activity of subthalamic nucleus and substantia nigra reticulata neurons.
    Mamad O; Delaville C; Benjelloun W; Benazzouz A
    PLoS One; 2015; 10(3):e0119152. PubMed ID: 25742005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unilateral nigrostriatal lesions induce a bilateral increase in glutamate decarboxylase messenger RNA in the reticular thalamic nucleus.
    Delfs JM; Ciaramitaro VM; Soghomonian JJ; Chesselet MF
    Neuroscience; 1996 Mar; 71(2):383-95. PubMed ID: 9053794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit.
    Baunez C; Nieoullon A; Amalric M
    J Neurosci; 1995 Oct; 15(10):6531-41. PubMed ID: 7472415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions.
    Mehta A; Menalled L; Chesselet MF
    Neuroscience; 2005; 131(3):769-78. PubMed ID: 15730880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.
    Lawler CP; Gilmore JH; Watts VJ; Walker QD; Southerland SB; Cook LL; Mathis CA; Mailman RB
    Synapse; 1995 Dec; 21(4):299-311. PubMed ID: 8869160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
    Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.